Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Core Scientific (CORZ) EBT Margin: 2021-2025

Historic EBT Margin for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -180.68%.

  • Core Scientific's EBT Margin rose 29662.00% to -180.68% in Q3 2025 from the same period last year, while for Sep 2025 it was -229.65%, marking a year-over-year decrease of 652.00%. This contributed to the annual value of -257.34% for FY2024, which is 20841.00% down from last year.
  • Latest data reveals that Core Scientific reported EBT Margin of -180.68% as of Q3 2025, which was up 84.83% from -1,191.23% recorded in Q2 2025.
  • Core Scientific's EBT Margin's 5-year high stood at 730.46% during Q1 2025, with a 5-year trough of -1,191.23% in Q2 2025.
  • Moreover, its 3-year median value for EBT Margin was -137.64% (2023), whereas its average is -184.75%.
  • Examining YoY changes over the last 5 years, Core Scientific's EBT Margin showed a top increase of 61,283bps in 2025 and a maximum decrease of 62,090bps in 2025.
  • Quarterly analysis of 5 years shows Core Scientific's EBT Margin stood at 25.50% in 2021, then slumped by 40,186bps to -376.36% in 2022, then surged by 23,872bps to -137.64% in 2023, then plummeted by 14,170bps to -279.34% in 2024, then surged by 29,662bps to -180.68% in 2025.
  • Its last three reported values are -180.68% in Q3 2025, -1,191.23% for Q2 2025, and 730.46% during Q1 2025.